Article
Cardiac & Cardiovascular Systems
Ahmed Mohamed Naguib, Mohamed Ahmed Sobhi, Amr Zaki, Ahmed Mahmoud El Amrawy
Summary: In this study, the authors compared the clinical and angiographic outcomes between the use of a single long stent and overlapping stents in patients with long coronary artery disease. They found that there was no significant difference in the efficacy between the two strategies. However, the use of overlapping stents was associated with higher contrast volume and fluoroscopy time.
Article
Medicine, General & Internal
Juan F. Iglesias, Marco Roffi, Sylvain Losdat, Olivier Muller, Sophie Degrauwe, David J. Kurz, Laurent Haegeli, Daniel Weilenmann, Christoph Kaiser, Maxime Tapponnier, Stephane Cook, Florim Cuculi, Dik Heg, Stephan Windecker, Thomas Pilgrim
Summary: In patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention, biodegradable polymer sirolimus-eluting stents were found to be superior to durable polymer everolimus-eluting stents in terms of target lesion failure at 5 years of follow-up.
Article
Cardiac & Cardiovascular Systems
Jung-Min Ahn, Do-Yoon Kang, Sung-Cheol Yun, Seung Ho Hur, Hun-Jun Park, Damras Tresukosol, Woong Chol Kang, Hyuck Moon Kwon, Seung-Woon Rha, Do-Sun Lim, Myung-Ho Jeong, Bong-Ki Lee, He Huang, Young Hyo Lim, Jang Ho Bae, Byung Ok Kim, Tiong Kiam Ong, Sung Gyun Ahn, Cheol-Hyun Chung, Duk-Woo Park, Seung-Jung Park
Summary: There were no significant differences between PCI and CABG in the long-term outcomes of patients with multivessel coronary artery disease.
Article
Cardiac & Cardiovascular Systems
Salvatore Brugaletta, Josep Gomez-Lara, Luis Ortega-Paz, Victor Jimenez-Diaz, Marcelo Jimenez, Pilar Jimenez-Quevedo, Roberto Diletti, Vicente Mainar, Gianluca Campo, Antonio Silvestro, Jaume Maristany, Xacobe Flores, Loreto Oyarzabal, Antonio De Miguel-Castro, Andres Iniguez, Antonio Serra, Luis Nombela-Franco, Alfonso Ielasi, Maurizio Tespili, Mattie Lenzen, Nieves Gonzalo, Pascual Bordes, Matteo Tebaldi, Simone Biscaglia, Juan Jose Rodriguez-Arias, Soheil Al-Shaibani, Victor Arevalos, Rafael Romaguera, Joan Antoni Gomez-Hospital, Patrick W. Serruys, Manel Sabate
Summary: This study assessed the 10-year outcomes of patients with STEMI treated with EES or bare-metal stents, demonstrating superior outcomes in both patient-oriented and device-oriented composite endpoints in the EES group. Low rates of adverse cardiovascular events related to device failure were found in both groups between 5- and 10-year follow-up.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Pediatrics
Ilaria Maccora, Giovanni Battista Calabri, Silvia Favilli, Alice Brambilla, Sandra Trapani, Edoardo Marrani, Gabriele Simonini
Summary: The study described the clinical and epidemiological characteristics of a Kawasaki syndrome cohort, identified risk factors for coronary artery lesions, and demonstrated the benign course of the syndrome with timely treatment in long-term follow-up over 36 years.
EUROPEAN JOURNAL OF PEDIATRICS
(2021)
Article
Cardiac & Cardiovascular Systems
David E. Kandzari, Jacques J. Koolen, Gheorghe Doros, Hector M. Garcia-Garcia, Johan Bennett, Ariel Roguin, Elie G. Gharib, Donald E. Cutlip, Ron Waksman
Summary: This study compared the late-term (5-year) clinical outcomes of ultra-thin strut bioresorbable polymer sirolimus-eluting stents (BP SES) with thin strut durable polymer everolimus-eluting stents (DP EES). The results showed that BP SES was associated with a lower occurrence of target vessel-related myocardial infarction and late/very late definite/probable stent thrombosis.
JACC-CARDIOVASCULAR INTERVENTIONS
(2022)
Review
Cardiac & Cardiovascular Systems
Mahesh Madhavan, James P. Howard, Azim Naqvi, Ori Ben-Yehuda, Bjorn Redfors, Megha Prasad, Bahira Shahim, Martin B. Leon, Sripal Bangalore, Gregg W. Stone, Yousif Ahmad
Summary: This study found that ultrathin-strut DES reduced the risk of long-term TLF compared with conventional 2nd-generation thin-strut DES, mainly driven by a reduction in CD-TLR risk.
EUROPEAN HEART JOURNAL
(2021)
Article
Cardiac & Cardiovascular Systems
Yeong Jin Jeong, Jung-Min Ahn, Junho Hyun, Junghoon Lee, Ju Hyeon Kim, Yujin Yang, Kyungjin Choe, Hanbit Park, Do-Yoon Kang, Pil Hyung Lee, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park, Duk-Woo Park
Summary: The study found no significant difference between DES and CABG in terms of MACCE rates, serious composite outcome, and all-cause mortality in patients with and without diabetes mellitus with left main coronary artery disease in the 10-year extended follow-up of the PRECOMBAT trial.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2021)
Article
Medicine, General & Internal
Marc S. Sabatine, Brian A. Bergmark, Sabina A. Murphy, Patrick T. O'Gara, Peter K. Smith, Patrick W. Serruys, A. Pieter Kappetein, Seung-Jung Park, Duk-Woo Park, Evald H. Christiansen, Niels R. Holm, Per H. Nielsen, Gregg W. Stone, Joseph F. Sabik, Eugene Braunwald
Summary: A comparison of long-term outcomes between PCI with drug-eluting stents and CABG in patients with left main coronary artery disease showed no significant difference in 5-year all-cause mortality. However, differences were observed in rates of myocardial infarction, stroke, and repeat revascularisation, with higher risks associated with PCI. A Bayesian approach suggested a slight advantage favoring CABG in terms of mortality.
Article
Medicine, General & Internal
Na Xu, Lin Jiang, Yi Yao, Jingjing Xu, Ru Liu, Huanhuan Wang, Ying Song, Lijian Gao, Zhan Gao, Xueyan Zhao, Bo Xu, Yaling Han, Jinqing Yuan
Summary: This study compares the clinical outcomes of using biodegradable polymer drug-eluting stents (BP-DES) and durable polymer drug-eluting stents (DP-DES) in complex percutaneous coronary intervention (CPCI). The results show that both CPCI and non-CPCI patients have a risk of adverse events in the mid- to long-term, and the effects of BP-DES and DP-DES differ in CPCI patients.
CHINESE MEDICAL JOURNAL
(2023)
Review
Cardiac & Cardiovascular Systems
Aakash Garg, Amit Rout, Raj Tayal, Abhishek Sharma, Sahil Agrawal, John B. Kostis, Marc Cohen, Samin Sharma, Najam Wasty
Summary: This meta-analysis did not find strong evidence for routine DES use in patients undergoing SVG intervention. Compared to BMS, DES showed similar risks in terms of all-cause death, cardiac death, myocardial infarction, target vessel revascularization, and target lesion revascularization.
CURRENT PROBLEMS IN CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Hyo-Soo Kim, Jeehoon Kang, Doyeon Hwang, Jung-Kyu Han, Han-Mo Yang, Hyun-Jae Kang, Bon-Kwon Koo, Seok Yeon Kim, Keun-Ho Park, Seung-Woon Rha, Won-Yong Shin, Hong-Seok Lim, Kyungil Park, Kyung Woo Park
Summary: The study demonstrated that in patients with acute coronary syndrome (ACS), durable polymer drug-eluting stents (DP-DES) were noninferior to biodegradable polymer DES (BP-DES) in terms of patient-oriented composite outcomes at 12 months after percutaneous coronary intervention.
Article
Peripheral Vascular Disease
Ignacio Sanchez-Perez, Jose Abellan-Huerta, Alfonso Jurado-Roman, Maria T. Lopez-Lluva, Natalia Pinilla-Echeverri, Pedro Perez-Diaz, Jesus Piqueras-Flores, Fernando Lozano-Ruiz-Poveda
Summary: The study concludes that the second generation paclitaxel-eluting balloon (PEB) is a safe and effective tool for treating in-stent restenosis and de novo coronary lesions, especially in small vessel disease, during long-term follow-up.
Article
Cardiac & Cardiovascular Systems
Frederik M. Zimmermann, Victoria Y. Ding, Nico H. J. Pijls, Zsolt Piroth, Albert H. M. van Straten, Laszlo Szekely, Giedrius Davidavicius, Gintaras Kalinauskas, Samer Mansour, Rajesh Kharbanda, Nikolaos Ostlund-Papadogeorgos, Adel Aminian, Keith G. Oldroyd, Nawwar Al-Attar, Nikola Jagic, Jan-Henk E. Dambrink, Petr Kala, Oskar Angeras, Philip MacCarthy, Olaf Wendler, Filip Casselman, Nils Witt, Kreton Mavromatis, Steven E. S. Miner, Jaydeep Sarma, Thomas Engstrom, Evald H. Christiansen, Pim A. L. Tonino, Michael J. Reardon, Hisao Otsuki, Yuhei Kobayashi, Mark A. Hlatky, Kenneth W. Mahaffey, Manisha Desai, Y. Joseph Woo, Alan C. Yeung, Bernard De Bruyne, William F. Fearon
Summary: There was no difference in the incidence of the composite of death, MI, or stroke after FFR-guided PCI with current-generation drug-eluting stents compared with CABG. There was a higher incidence of MI after PCI compared with CABG, with no difference in death or stroke.
Article
Medicine, General & Internal
Seok Oh, Myung Ho Jeong, Dae Sung Park, Munki Kim, Jung Ha Kim, Dae Young Hyun, Kyung Hoon Cho, Min Chul Kim, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn
Summary: This study reports a case of TIGEREVOLUTION stent implantation with an 8-month follow-up OCT, showing good stent patency with no definitive evidence of in-stent restenosis, and thin stent strut coverage demonstrated on optical coherence tomography.